Essential Tremor Treatment Market Size, Share, Growth, and Industry Analysis, By Type (NBI-640756, SAGE-217, Sepranolone & Others), By Application (Research Center, Clinic, Hospital & Others), Regional Insights and Forecast From 2025 To 2034

• 

  Download Free Sample to learn more about this report

ESSENTIAL TREMOR TREATMENT MARKET OVERVIEW

Global Essential Tremor Treatment market is estimated at USD 0.169 billion in 2025, anticipated to increase to USD 0.178 billion in 2026, and projected to reach USD 0.254 billion by 2034, growing at a CAGR of 5.3% from 2025 to 2034.

A neurological condition of the nervous system called essential tremor results in rhythmic and involuntary shaking. Your hands tremble the most frequently, especially when performing simple tasks like drinking from a glass or tying your shoes. It can affect almost any part of your body. While essential tremor treatment is often not harmful, it can be severe in certain people and tends to get worse over time.

Essential tremor treatment happens when a person utilizes their hands, but Parkinson's disease tremors happen when the hands are at rest. When this condition is advanced, it can seriously impair some of life's most fundamental activities and activities, including eating, drinking, and clothing oneself. Many patients additionally battle with anxiety or feelings of embarrassment related to the condition's symptoms. Treatment for tremors will solve this issue and aid in the patient's recovery.

Key Findings 

COVID-19 IMPACT

Disturbances in Sales Causes Market Distortion

The global COVID-19 pandemic has been unprecedented and staggering, with the essential tremor treatment market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market's growth and demand returning to pre-pandemic levels once the pandemic is over.

The COVID-19 epidemic caused problems for healthcare companies like volatile markets, a drop in customer confidence, and difficulties with import and export transactions. Markets were shut down and people stayed at home due to the lockdown. Supply chain breaches, stock market inefficiencies and vendor instability are the results of this advance. The halt on healthcare industry affected the whole market. Due to shutdown of markets, there was increasing number of patients and the usage of essential tremor treatment has expanded significantly, the demand for product was also got increased due to COVID-19. The pandemic impacted the industry dynamics, forcing organizations to revamp their entire operation structures to maintain stability amid the disruptions the financial imbalance that occurs due to shutdown of various stores & large sectors was the main reason that distorted the whole market. Aside from that, the companies' business operations have been affected by the outbreak, which has an effect on the overall essential tremor treatment industry. This has partially impacted the essential tremor treatment market.

LATEST TRENDS

Ultrasound Treatment to Boost the Market Growth

Focused ultrasound is used to treat essential tremor by locating and eliminating the little area of brain tissue that causes it. For the essential tremor treatment, focused ultrasound thalamotomy is a unique kind of focused ultrasound procedure. Since there are no incisions made during the treatment, healing is quick and, for the most part, painless. Other medical diseases that can be treated using focused ultrasound include Parkinson's disease, uterine fibroids, and to limit the spread of some malignancies. When the patient undergoes a specialized CT scan as part of the examination, the candidate is good for focused ultrasonic thalamotomy. Due to the patient's pacemaker or other implanted device, targeted ultrasound thalamotomy without CT scan may not be an option for them. Thus, the usage of ultrasound as a therapy is a main trend which is creating opportunities for the market to boost. The market's total expansion is primarily due to all these new developments.

• According to a meta-analysis covering 42 population-based studies in 23 countries, the pooled prevalence of essential tremor among all ages was estimated at 1.33%, while among individuals aged 65 or older it was about 5.79%.

• According to data from the U.K., the average crude incidence rate of essential tremor was 18.20 per 100,000 person-years in the UK and 21.42 per 100,000 person-years in France (2014-19 period).

Download Free Sample to learn more about this report

ESSENTIAL TREMOR TREATMENT MARKET SEGMENTATION

By Type

Based on type, the market is classified into NBI-640756, SAGE-217, Sepranolone & Others.

By Application

Based on application, the market is categorized Research Center, Clinic, Hospital & Others.

DRIVING FACTORS

Rising Incidence of neurological disease that Gives the Market Extra Boost

The majority of disabilities globally are still caused by neurological problems, and these conditions are now adding more to the overall burden of all illnesses. The majority of the burden caused by neurological illnesses still falls on low- and middle-income nations. To enable evidence-based healthcare planning and resource allocation for neurological illnesses, regular updates on the global, regional, and national burden of neurological disorders are required due to population ageing, population increase, and ongoing epidemiological transition across all nations. A rise in the prevalence of neurological illnesses among people worldwide is also influencing this market's ability to create more money. This will produce the ideal opportunity to increase the market. As a result, the growth, and the importance of devices in hospital and clinic and will boost the market. It will contribute to the expansion of the healthcare industry and it will improve the overall essential tremor treatment market growth.

SAGE-217 Treatment to Encourage Market Expansion

A once daily, two-week medication called zuranolone (SAGE-217/BIIB125) is being developed to treat major depressive disorder (MDD) and postpartum depression (PPD). Zuranolone is a GABA-A receptor positive allosteric modulator that is an experimental oral neuroactive steroids (NAS) (PAM). The designation of "Breakthrough Therapy" has been given to Zuranolone. Zuranolone is being examined as a possible quick-acting medication. This medication aids in the disease's cure and is a key element in the market's expansion. As a result, during the projected period, the market for healthcare is anticipated to rise rapidly. The advancement of the product is helping the market to grow.

• According to the journal Tremor & Other Hyperkinetic Movements, in the U.S. the estimated number of adults with essential tremor ranged from 6.38 million to 7.63 million, representing approximately 2.2% of the U.S. population.

• As reported by the International Essential Tremor Foundation, it is estimated that between 7 million and 10 million Americans have essential tremor, underscoring a significant base of potential treatment-eligible individuals.

RESTRAINING FACTORS

High Cost of Product to Impede Market Expansion

Despite having a promising growth trajectory, a number of challenges are significantly reducing the essential tremor treatment expansion. These include the unavailability of these products in developing nations, the inconsistent performance of treatment process and equipment’s at times, and the expensive price of the whole procedure and equipment. Therefore, a significant factor limiting the growth of this market are its high maintenance and high cost. If this problem is fixed, the market will start to grow right away.

• According to a guideline review published in Neurology, among a clinical database of 223 patients with essential tremor, 70.9% had been treated with primidone or propranolol, but 56.3% of them discontinued one or both medications due to tolerability or lack of effect.

• According to research in Tremor and Other Hyperkinetic Movements, a real-world study found that 12.7% of respondents (N = 1,418) reported needing a more quantitative and objective way of assessing their tremor and tracking progression — indicating a deficit in current monitoring tools.

• Download Free Sample to learn more about this report

•  

ESSENTIAL TREMOR TREATMENT MARKET REGIONAL INSIGHTS

Rapid Urbanization to Dominate Market in North America

The market for essential tremor treatment in North America has benefited from the region's expanding industrial development, and various driving factors which has increased the potential sectors as this region is the largest user of the product. The key factor driving the growth of the essential tremor treatment market share is their growing demand of various treatment in hospitals, clinics and various centers is one of the major reasons to drive the market. Rapid urbanization developments will further boost the overall market.

KEY INDUSTRY PLAYERS

Leading Manufacturers to Boost Product Demand

The research provides details on the list of market participants and their activity in the sector. Acquisitions, mergers, technical advancements, collaborations, and increasing production facilities are used to gather and report the information. The companies that produce and introduce new products, the areas where they operate, automation, technology adoption, creating the greatest income, and making a difference with their products are some of the other factors that are looked at for this market.

• Merz Pharma GmbH & Co. KGaA (Germany): According to clinical trial registries, the company’s focused-ultrasound therapy for essential tremor targets fewer than 10 % of eligible patients in specialized neurology centres, reflecting early adoption.

• Neurocrine Biosciences Inc (U.S.): Public sources indicate the company enrolled 420 patients in a mid-stage essential tremor trial for its experimental treatment (suvecaltamide).

List of Top Essential Tremor Treatment Companies

• Merz Pharma GmbH & Co. KGaA (Germany)   
• Neurocrine Biosciences Inc (U.S.)
• Sage Therapeutics (U.S.)

REPORT COVERAGE

The segmentation of the market by type and application is covered in detail in the study. A wide spectrum of players, including current and potential market leaders, are examined in the study. A number of significant reasons are expected to fuel a sizable market expansion. The research also includes factors that are probably to increase essential tremor treatment market share in order to provide market insights. The report also contains predictions for market growth during the anticipated time frame. Clarifying why one region dominates the global market is the aim of the regional study. The market is unable to expand due to a number of problems, all of which have been carefully taken into account. The research also contains a market strategic analysis. It includes thorough market information.